title: Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration.
authors.affiliation: Save Sight Institute, University of Sydney, Sydney, NSW, Australia.
authors.forename: Anagha
authors.initials: A
authors.lastname: Vaze
authors.forename: Samantha
authors.initials: S
authors.lastname: Fraser-Bell
authors.forename: Mark
authors.initials: M
authors.lastname: Gillies
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069579:Ranibizumab; D012008:Recurrence; D012189:Retrospective Studies; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D057135:Wet Macular Degeneration / Q000175:diagnosis* / Q000188:drug therapy*; D028761:Withholding Treatment
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab